Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Conquest Resources Shareholders Approve Belfast-Teck Mag Property Sale to Inventus Mining

Conquest Resources Shareholders Approve Belfast-Teck Mag Property Sale to Inventus Mining

BitgetBitget2026/11/04 23:10
  • Conquest Resources shareholders unanimously approved selling its 100% interest in Belfast-Teck Mag to Inventus Mining on November 4, 2026.
  • The property package includes the historic Golden Rose Mine; consideration includes 8,000,000 Inventus common shares.
  • Additional consideration comprises a 2% net smelter returns royalty on applicable mineral claims not already subject to an existing royalty.
  • Inventus can purchase 0.5% of the royalty for C$ 1 million.
  • Closing remains subject to outstanding conditions, including TSX Venture Exchange acceptance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conquest Resources Limited published the original content used to generate this news brief via Newsfile (Ref. ID: 202611041715NEWSFILECNPR____20261104_322543_1) on November 04, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss